|
31 |
Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: New aspects after the fall of the pyramid and the rise of new therapeutics Enthalten in Current rheumatology reports Bd. 5, Nr. 6, date:12.2003: 409-412
|
|
|
32 |
The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care Enthalten in Current rheumatology reports Bd. 5, Nr. 5, date:10.2003: 336-340
|
|
|
33 |
Usmierzyc bol Smolen, Josef S.. - Warszawa : Diogenes, 2002
|
Verlagsmeldung
|
|
34 |
Leflunomid bei der rheumatoiden Arthritis Enthalten in Arzneimittelforschung Bd. 50, 2000, Nr. 02: 194-195
|
|
|
35 |
Leben ohne Schmerzen Smolen, Josef S.. - Wien : Ueberreuter, 1999
|
|
|
36 |
Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins — A link between RA, SLE and MCTD Enthalten in Molecular biology reports Bd. 23, Nr. 3-4, date:9.1996: 167-171
|
|
|
37 |
Systemic Lupus Erythematosus Berlin, Heidelberg : Springer Berlin Heidelberg, 1995
|
|
|
38 |
Rheumatoid Arthritis Berlin, Heidelberg : Springer Berlin Heidelberg, 1992
|
|
|
39 |
Rheumatoid arthritis Berlin : Springer, 1992
|
|
|
40 |
Systemic Lupus erythematosus Berlin : Springer, 1987
|
|